联用治疗-话题@MedSci

#联用治疗#

9篇内容 | 324人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1807745, encodeId=4aa4180e745c7, content=<a href='/topic/show?id=3fe480e46e5' target=_blank style='color:#2F92EE;'>#联用治疗#</a>, objectTitle=Stroke：替格瑞洛-阿司匹林联用治疗卒中，利大于弊, objectType=article, longId=216825, objectId=457421682544, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=457421682544, replyNumber=0, likeNumber=49, createdTime=2022-08-14, rootId=0, userName=chenhongpeng, userId=1777154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=457421682544, moduleTitle=Stroke：替格瑞洛-阿司匹林联用治疗卒中，利大于弊, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=457421682544)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807744, encodeId=2654180e744aa, content=<a href='/topic/show?id=3fe480e46e5' target=_blank style='color:#2F92EE;'>#联用治疗#</a>, objectTitle=Eur Urol Oncol：雄激素阻断疗法与多西他赛联用治疗高风险生化复发前列腺癌, objectType=article, longId=212395, objectId=fb5e21239575, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fb5e21239575, replyNumber=0, likeNumber=47, createdTime=2021-09-11, rootId=0, userName=chenhongpeng, userId=1777154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fb5e21239575, moduleTitle=Eur Urol Oncol：雄激素阻断疗法与多西他赛联用治疗高风险生化复发前列腺癌, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=fb5e21239575)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807743, encodeId=bf59180e743f1, content=<a href='/topic/show?id=3fe480e46e5' target=_blank style='color:#2F92EE;'>#联用治疗#</a>, objectTitle=Gynecol Endocrinol：α-硫辛酸与甲非那酸联用治疗原发性痛经, objectType=article, longId=196953, objectId=236f1969532a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=236f1969532a, replyNumber=0, likeNumber=39, createdTime=2020-12-16, rootId=0, userName=chenhongpeng, userId=1777154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=236f1969532a, moduleTitle=Gynecol Endocrinol：α-硫辛酸与甲非那酸联用治疗原发性痛经, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=236f1969532a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807742, encodeId=b58b180e742c2, content=<a href='/topic/show?id=3fe480e46e5' target=_blank style='color:#2F92EE;'>#联用治疗#</a>, objectTitle=ASCO2019|TACE + RFA联用治疗中期（BCLC B期）肝癌改善患者生存期, objectType=article, longId=167670, objectId=f89f16e6704f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=f89f16e6704f, replyNumber=0, likeNumber=28, createdTime=2019-12-06, rootId=0, userName=chenhongpeng, userId=1777154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=f89f16e6704f, moduleTitle=ASCO2019|TACE + RFA联用治疗中期（BCLC B期）肝癌改善患者生存期, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=f89f16e6704f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807740, encodeId=0a3b180e7408e, content=<a href='/topic/show?id=3fe480e46e5' target=_blank style='color:#2F92EE;'>#联用治疗#</a>, objectTitle=The Lancet Infectious Diseases：ledipasvir与sofosbuvir联用治疗HCV-HIV共感染患者, objectType=article, longId=94431, objectId=ed25944312b, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ed25944312b, replyNumber=0, likeNumber=25, createdTime=2018-02-09, rootId=0, userName=chenhongpeng, userId=1777154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ed25944312b, moduleTitle=The Lancet Infectious Diseases：ledipasvir与sofosbuvir联用治疗HCV-HIV共感染患者, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ed25944312b)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807741, encodeId=80d3180e7419f, content=<a href='/topic/show?id=3fe480e46e5' target=_blank style='color:#2F92EE;'>#联用治疗#</a>, objectTitle=ASH 2017】BCL2抑制剂venetoclax与伊布替尼联用治疗初诊未治高危和复发难治CLL的二期临床研究结果, objectType=article, longId=120735, objectId=9988120e352a, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=9988120e352a, replyNumber=0, likeNumber=26, createdTime=2018-05-15, rootId=0, userName=chenhongpeng, userId=1777154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=9988120e352a, moduleTitle=ASH 2017】BCL2抑制剂venetoclax与伊布替尼联用治疗初诊未治高危和复发难治CLL的二期临床研究结果, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=9988120e352a)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807739, encodeId=50ea180e739bc, content=<a href='/topic/show?id=3fe480e46e5' target=_blank style='color:#2F92EE;'>#联用治疗#</a>, objectTitle=Nat med：药物联用治疗胰腺癌显奇效, objectType=article, longId=56581, objectId=d51e565812f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=d51e565812f, replyNumber=0, likeNumber=29, createdTime=2015-11-21, rootId=0, userName=chenhongpeng, userId=1777154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=d51e565812f, moduleTitle=Nat med：药物联用治疗胰腺癌显奇效, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d51e565812f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807738, encodeId=7333180e7386b, content=<a href='/topic/show?id=3fe480e46e5' target=_blank style='color:#2F92EE;'>#联用治疗#</a>, objectTitle=Lancet：多药联用治疗慢性丙肝, objectType=article, longId=48968, objectId=a115489686f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a115489686f, replyNumber=0, likeNumber=28, createdTime=2016-02-16, rootId=0, userName=chenhongpeng, userId=1777154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a115489686f, moduleTitle=Lancet：多药联用治疗慢性丙肝, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=a115489686f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1807737, encodeId=c881180e737f4, content=<a href='/topic/show?id=3fe480e46e5' target=_blank style='color:#2F92EE;'>#联用治疗#</a>, objectTitle=ADA2013：阿格列汀与二甲双胍联用治疗糖尿病效果好, objectType=article, longId=20710, objectId=ca3a20e10cc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=ca3a20e10cc, replyNumber=0, likeNumber=47, createdTime=2014-04-05, rootId=0, userName=chenhongpeng, userId=1777154, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=ca3a20e10cc, moduleTitle=ADA2013：阿格列汀与二甲双胍联用治疗糖尿病效果好, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=ca3a20e10cc)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

联用治疗

2020-05-29

chenhongpeng (审核中...)

前往app查看评论内容

#联用治疗#

Stroke：替格瑞洛-阿司匹林联用治疗卒中，利大于弊

2022-08-14

chenhongpeng (审核中...)

前往app查看评论内容

#联用治疗#

Eur Urol Oncol：雄激素阻断疗法与多西他赛联用治疗高风险生化复发前列腺癌

2021-09-11

chenhongpeng (审核中...)

前往app查看评论内容

#联用治疗#

Gynecol Endocrinol：α-硫辛酸与甲非那酸联用治疗原发性痛经

2020-12-16

chenhongpeng (审核中...)

前往app查看评论内容

#联用治疗#

ASCO2019|TACE + RFA联用治疗中期（BCLC B期）肝癌改善患者生存期

2019-12-06

chenhongpeng (审核中...)

前往app查看评论内容

#联用治疗#

The Lancet Infectious Diseases：ledipasvir与sofosbuvir联用治疗HCV-HIV共感染患者

2018-02-09

chenhongpeng (审核中...)

前往app查看评论内容

#联用治疗#

ASH 2017】BCL2抑制剂venetoclax与伊布替尼联用治疗初诊未治高危和复发难治CLL的二期临床研究结果

2018-05-15

chenhongpeng (审核中...)

前往app查看评论内容

#联用治疗#

Nat med：药物联用治疗胰腺癌显奇效

2015-11-21

chenhongpeng (审核中...)

前往app查看评论内容

#联用治疗#

Lancet：多药联用治疗慢性丙肝

2016-02-16

chenhongpeng (审核中...)

前往app查看评论内容

#联用治疗#

ADA2013：阿格列汀与二甲双胍联用治疗糖尿病效果好

2014-04-05

科室
- - 订阅+
  - 更多科室
工具
服务